{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE344nnn/GSE344237/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Transcriptomics"],"species":["Mus musculus"],"gds_type":["Expression profiling by array"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE344237"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"Co-Administration of Trans-Resveratrol and L-Carnitine with a High-Fat and High-Carbohydrate Diet Modulates Liver Transcriptome in Obesity-Resistant DBA/2J Mice","description":"This study investigated the effects of combined trans-resveratrol and L-carnitine supplementation on the liver transcriptome of male DBA/2J mice, a strain resistant to diet-induced obesity. Mice received either a control diet (CD) or a high-fat-high-carbohydrate diet (HFCD) for 64 days, with no supplement, a low-dose resveratrol/L-carnitine combination (RCl; 25/300 mg/kg body weight/day), or a high-dose combination (RCh; 50/600 mg/kg body weight/day). Liver gene expression was profiled using Agilent SurePrint G3 Mouse Gene Expression v2 8x60K one-color microarrays.","dates":{"publication":"2026/09/03"},"accession":"GSE344237","cross_references":{"GSM":["GSM9973381","GSM9973370","GSM9973380","GSM9973390","GSM9973369","GSM9973368","GSM9973379","GSM9973367","GSM9973389","GSM9973378","GSM9973377","GSM9973388","GSM9973387","GSM9973376","GSM9973386","GSM9973375","GSM9973374","GSM9973385","GSM9973384","GSM9973373","GSM9973372","GSM9973383","GSM9973382","GSM9973371"],"GPL":["21163"],"GSE":["344237"],"taxon":["Mus musculus"],"PMID":["[42737701]"]}}